Achieve Life Sciences names Dr. Mark Rubinstein interim CMO
Go back to Achieve Life Sciences names Dr. Mark Rubinstein interim CMO| (NASDAQ: ACHV) | Delayed: 6.11 -0.29 (4.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.40 | 52 Week High | $ | |||
| Open | $6.37 | 52 Week Low | $ | |||
| Day High | $6.40 | P/E | N/A | |||
| Day Low | $5.81 | EPS | $ | |||
| Volume | 2,050,656 | |||||

